FUMAGALLI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 5.140
EU - Europa 2.565
AS - Asia 1.730
SA - Sud America 71
AF - Africa 24
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.557
Nazione #
US - Stati Uniti d'America 5.065
SG - Singapore 687
CN - Cina 533
IT - Italia 506
DE - Germania 432
SE - Svezia 430
RU - Federazione Russa 423
IE - Irlanda 269
HK - Hong Kong 180
GB - Regno Unito 162
VN - Vietnam 104
UA - Ucraina 77
CA - Canada 69
DK - Danimarca 66
BR - Brasile 63
FR - Francia 56
ID - Indonesia 52
IN - India 45
TR - Turchia 42
AT - Austria 32
FI - Finlandia 25
JP - Giappone 25
KR - Corea 22
NL - Olanda 21
AU - Australia 20
BE - Belgio 20
ES - Italia 10
ZA - Sudafrica 10
EG - Egitto 9
IR - Iran 9
TW - Taiwan 8
HR - Croazia 6
RO - Romania 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
EU - Europa 5
BG - Bulgaria 4
PT - Portogallo 4
SA - Arabia Saudita 4
KZ - Kazakistan 3
PK - Pakistan 3
RS - Serbia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
GT - Guatemala 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PY - Paraguay 2
SC - Seychelles 2
TH - Thailandia 2
UY - Uruguay 2
AR - Argentina 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
IQ - Iraq 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 9.557
Città #
Ann Arbor 1.897
Singapore 476
Wilmington 346
Chandler 323
Dublin 261
Frankfurt am Main 258
Dearborn 236
Milan 215
Ashburn 187
Woodbridge 185
Hong Kong 180
Houston 145
New York 140
Fairfield 139
Princeton 134
Santa Clara 122
Nanjing 112
Jacksonville 86
Boardman 76
Seattle 65
Guangzhou 55
Jakarta 46
Shanghai 43
Nanchang 42
Dong Ket 41
Cambridge 37
Lawrence 32
Beijing 30
Shenyang 29
Vienna 29
Los Angeles 28
Altamura 26
Moscow 26
Hangzhou 23
Shangdi 21
Jinan 20
Pune 20
Ottawa 19
Zhengzhou 19
Toronto 18
Brussels 17
Council Bluffs 17
Kunming 17
Sacramento 16
Andover 15
Fremont 15
Sydney 15
Falls Church 14
Kocaeli 14
Mainz 14
Portland 14
Edmonton 12
San Diego 12
Tianjin 12
Changsha 11
Helsinki 11
Lissone 11
Chicago 10
Dallas 10
Norwalk 10
Nuremberg 10
Hebei 9
Jiaxing 9
Lachine 9
Coventry 8
Düsseldorf 8
Kiev 8
Yuseong-gu 8
Canazei 7
Grafing 7
Cagliari 6
Chengdu 6
Codroipo 6
Frederick 6
Hefei 6
London 6
Paris 6
Philadelphia 6
Phoenix 6
Rome 6
Induno Olona 5
Merate 5
Montreal 5
Ningbo 5
Pavia 5
Taizhou 5
Takasago 5
Zagreb 5
Belo Horizonte 4
Boston 4
Brno 4
Cairo 4
Carate Brianza 4
Cislago 4
Duncan 4
Falkenstein 4
Fuzhou 4
Laurel 4
Lauterbourg 4
Leawood 4
Totale 6.685
Nome #
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 313
The role of Neurofilament Light Chain as a serum biomarker in chemotherapy-induced peripheral neurotoxicity rat models 306
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 279
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 251
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 239
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 231
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 230
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 229
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 226
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 223
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 218
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 212
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 207
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 207
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 206
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 194
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 192
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 192
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 184
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 179
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 168
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 164
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 164
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 160
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 156
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 147
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 146
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 144
Multimodal experimental approach to the study of human neurological diseases 143
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 143
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 143
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 142
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 141
Genetic factors influencing the development of vincristine-induced neurotoxicity 140
Long-term recovery from chemotherapy-induced neuropathy following paclitaxel, ixabepilone, eribulin and vinorelbine in mice 139
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 139
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 138
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 137
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 136
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 135
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 134
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 132
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 130
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 129
Oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 128
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 122
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 119
Pharmacokinetics of IVIg in Wistar rats 118
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 114
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 107
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 106
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 105
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 104
In vitro neurotoxicity of new promising metal-based anticancer complexes 104
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 104
Making connections: gap junctions are pivotal for MSC-induced long lasting survival of sensory neurons 102
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 101
Translational approach to chemotherapy induced peripheral neurotoxicity (cipn) – neurophysiology as the link between bench and bed-side 100
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 98
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 96
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 91
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 80
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 72
Blood NfL as a potential axonal damage marker in different CIPN rat models. 71
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 71
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 65
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 64
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 47
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 45
Assessment of Neurofilament Light Protein as a Serum Biomarker in Rodent Models of Toxic-Induced Peripheral Neuropathy 44
Totale 10.346
Categoria #
all - tutte 36.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020271 0 0 0 0 0 0 0 0 0 155 96 20
2020/20212.104 44 49 215 185 149 216 253 252 189 148 163 241
2021/20221.131 126 166 145 119 88 91 50 45 38 51 72 140
2022/20231.389 163 316 174 120 98 243 21 65 92 26 55 16
2023/20241.002 27 38 30 36 122 235 160 84 61 20 13 176
2024/20252.040 139 363 248 115 236 92 189 97 286 275 0 0
Totale 10.346